SCA Pharmaceuticals celebrated the official opening of its 90,000-square foot manufacturing facility on November 27, 2017. The private pharmaceutical company specializing in providing high quality sterile admixtures and prefilled syringes to hospitals and surgery centers, is located on Rainbow Road in Windsor, CT.

Governor Dannel Malloy and U.S. Senior Senator Richard Blumenthal highlighted a list of guests on hand to help cut the ribbon.

This new facility “helps us prove the economics of production in Connecticut,” said Gov. Malloy. “I think this is a great investment for the state [and] as they prove their success here, we’re hoping other companies will follow suit.”

As a leader in 503B industry, SCA partners with hospitals as an extension of their own pharmacy to provide safe medications for patients.

“We are very excited. Our new facility is another milestone in the rapid expansion of our company,” said Milton Boyer, chief executive officer, SCA. “The Connecticut location allows us to tap into the wealth of pharmaceutical talent in the state as well as position our company strategically to service our east coast clients. We appreciate the tremendous support we have received from the State of Connecticut. They have been an invaluable partner.”

Located just north of Hartford, SCA says the facility is designed to facilitate quicker turnaround times and enhance customer experiences. It features state of the art cGMP cleanrooms, and GLP Quality Control Laboratories to meet FDA quality regulations.

The new facility joins SCA’s existing Little Rock, AR location. The company employs more than 360 employees with over 140 in Connecticut. As the Windsor facility expands over the next 3 years, SCA plans to add over 200 additional full-time positions.